Brief: Talaris Therapeutics Announces Stockholder Approval Of Merger With Tourmaline Bio
17/10/2023 22:50
Oct 17 (Reuters) - Talaris Therapeutics Inc TALS.O :
* TALARIS THERAPEUTICS ANNOUNCES STOCKHOLDER APPROVAL OF
MERGER
WITH TOURMALINE BIO
* TALARIS THERAPEUTICS INC - TALARIS ANNOUNCES 1-FOR-10
REVERSE
STOCK SPLIT OF COMMON STOCK
Source text for Eikon: ID:nGNX5jjyrz
Further company coverage: TALS.O
Recent news on Tourmaline Bio
See all newsBrief: Novartis Completes Acquisition Of Tourmaline Bio
Brief: Novartis Announces Expiration Of Tourmaline Bio Tender Offer
Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports (updated)
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Tourmaline Bio
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy